<VariationArchive VariationID="832471" VariationName="NC_000021.9:g.(?_34792125)_(34892973_?)del" VariationType="Deletion" Accession="VCV000832471" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="821365" VariationID="832471">
      <GeneList>
        <Gene Symbol="RUNX1" FullName="RUNX family transcription factor 1" GeneID="861" HGNC_ID="HGNC:10471" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34787801" stop="35049302" display_start="34787801" display_stop="35049302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36160097" stop="36421594" display_start="36160097" display_stop="36421594" Strand="-" />
          </Location>
          <OMIM>151385</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000021.9:g.(?_34792125)_(34892973_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" innerStart="36164422" innerStop="36265270" display_start="36164422" display_stop="36265270" variantLength="100849" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.(?_36164422)_(36265270_?)del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.(?_36164422)_(36265270_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000021.9:g.(?_34792125)_(34892973_?)del AND Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" Accession="RCV001032955" Version="5">
        <ClassifiedConditionList TraitSetID="3994">
          <ClassifiedCondition DB="MedGen" ID="C1832388">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14504086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15749889</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22689681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23753029</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3994" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3980" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Platelet disorder, Aspirin-like</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ElementValue>
                <XRef ID="MONDO:0100083" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial platelet disorder with associated myeloid malignancy</ElementValue>
                <XRef ID="Familial+Platelet+Disorder+with+Associated+Myeloid+Malignancy/2765" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial thrombocytopenia with propensity to acute myelogenous leukemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPDMM</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPD/AML</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15329" />
                <XRef ID="15329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).</Attribute>
                <XRef ID="NBK568319" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="C1832388" DB="MedGen" />
              <XRef ID="C563324" DB="MeSH" />
              <XRef ID="MONDO:0100083" DB="MONDO" />
              <XRef Type="MIM" ID="601399" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357518" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_001754.4_21_Deletion (exons 3-9)|MedGen:C1832388" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196262" DateUpdated="2024-06-09" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14504086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15749889</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22689681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23753029</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3-9 of the RUNX1 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with RUNX1-related conditions. The region of the RUNX1 gene that includes exon(s) 8-9 has been determined to be clinically significant (PMID: 14504086, 15749889, 22689681, 23753029). Therefore, deletions that encompass that region are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.(?_36164422)_(36265270_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832388" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357518" TraitType="Disease" MappingType="XRef" MappingValue="C1832388" MappingRef="MedGen">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

